Average Co-Inventor Count = 8.39
ph-index = 10
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Chemocentryx, Inc. (49 from 214 patents)
2. Amgen Inc. (2 from 1,941 patents)
3. Other (1 from 832,347 patents)
52 patents:
1. 12371433 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
2. 12139475 - 2-oxindole compounds
3. 12018016 - Aryl sulfonyl (hydroxy) piperidines as CCR6 inhibitors
4. 12011439 - Combination therapy using C—C chemokine receptor 4 (CCR4) antagonists and one or more immune checkpoint inhibitors
5. 11945805 - Inhibitors of CXCR2
6. 11884654 - Substituted anilines as CCR(4) antagonists
7. 11872217 - Indanes as PD-L1 inhibitors
8. 11866429 - Heteroaryl-biphenyl amines for the treatment of PD-L1 diseases
9. 11820759 - Modulators of chemokine receptors
10. 11793771 - Immunomodulator compounds
11. 11759458 - Indane-amines as PD-L1 antagonists
12. 11713307 - Heteroaryl-biphenyl amides for the treatment of PD-L1 diseases
13. 11708326 - Immunomodulator compounds
14. 11684606 - Methods of treating generalized pustular psoriasis with an antagonist of CCR6 or CXCR2
15. 11485708 - Compounds for treatment of PD-L1 diseases